-
Medtronic changes investor relations leadership ahead of diabetes spinout
09 Dec 2025 22:59 GMT
… preferred path being a MiniMed initial public offering and subsequent split-off.
Investor … cell and gene therapy developer Bluebird Bio.
-
Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity
14 May 2025 17:39 GMT
Although talk of a recession has some investors spooked, stock market veterans like CNBC's Jim Cramer see it as an opportunity to pick up undervalued stocks. On a recent episode of "Mad Money," Cramer discussed the economy and two stocks he …
-
AI-Focused Biotech Unicorns Face Chilly Market Where IPOs Aren’t Guaranteed
16 Jul 2025 04:43 GMT
… . A classic example is bluebird bio, which at its peak … . For these companies, an initial public offering (IPO) might still be the best … In today’s volatile market, IPOs are no longer a guaranteed … to secure the approval of bluebird bio’s gene therapy Zynteglo, …
-
Struggling bluebird bio to go private for less than $30m
21 Feb 2025 21:16 GMT
Bluebird bio will be acquired by investment … .
Bluebird bio went public in 2013, raising approximately $116m through its IPO. The …
-
bluebird bio Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
03 Jan 2023 13:58 GMT
… Vittiglio guided the company’s initial public offering in 2021, which raised $ … product launches.
About bluebird bio, Inc.
bluebird bio is pursuing curative gene … and YouTube.
bluebird bio is a trademark of bluebird bio, Inc.
bluebird bio Cautionary Statement …
-
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
19 Sep 2022 13:15 GMT
… after declining 17% on Friday.
bluebird bio, Inc. BLUE rose 18. … 52 in pre-market trading. bluebird bio disclosed that the Food and … Friday. Nexalin Technology priced its IPO at $4.15 per … pre-market trading amid post-IPO volatility.
Marathon Digital Holdings, …
-
STAT+: Contineum Therapeutics files for IPO
18 Mar 2024 14:52 GMT
… labs, see a new biopharma IPO in the works, and expect … need-to-know this morning
Bluebird Bio, in the early stages of …
-
bluebird bio: Potential For 3 Gene Therapy Approvals In 12 Months Makes Buy Case
22 Jun 2022 18:43 GMT
… more than a decade, bluebird bio has helped chart the path … in a press release announcing bluebird bio's (NASDAQ:BLUE) … Beam Therapeutics (BEAM) has IPO'd, showcasing a potentially … bluebird Stock Looks Tempting bluebird bio has experienced more than …
-
Stock Down 98% From Peak, Bluebird Bio Could Run Out Of Cash
22 Apr 2022 18:15 GMT
… layoffs, Bluebird Bio’s cash position is weak
Bluebird Bio’s … March, Akebia Therapeutics, Bluebird Bio, and Yumanity Therapeutics … Globe.
Bluebird Bio’s Weak Cash Position
Bluebird Bio’s stock … name to bluebird bio, according to its IPO prospectus.
In …
-
Just after ASCO, China's Legend Biotech raises nearly $424M in initial public offering
08 Jun 2020 19:54 GMT
… $423.8 million in its initial public offering on the Nasdaq, under the … aimed for a $100 million IPO last month. Shares of the … a partnership between BMS and bluebird bio.
Photo: Spencer Platt, Getty Images
About
© 1995-2025